The Effect of Betahistine on Body Weight in Obese Subjects
Public ClinicalTrials.gov record NCT00409305. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Examine the Effect of Betahistine on Body Weight in Obese Subjects
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to examine the effect that betahistine has on body weight in obese subjects.
Study identification
- NCT ID
- NCT00409305
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 280 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2006
- Primary completion
- Not listed
- Completion
- May 31, 2007
- Last update posted
- Apr 20, 2015
2007
United States locations
- U.S. sites
- 19
- U.S. states
- 15
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cahaba Research, Inc. | Birmingham | Alabama | 35242 | — |
| Scripps Clinic, Nutrition Metabolic Research | San Diego | California | 92130 | — |
| Diablo Clinical Research, Inc. | Walnut Creek | California | 94598 | — |
| Miami Research Associates, Inc., Nutrition Division | Miami | Florida | 33143 | — |
| CSRA Partners in Health, Inc. | Augusta | Georgia | 30909 | — |
| Radiant Research, Inc. | Chicago | Illinois | 60610 | — |
| NCCR | Chicago | Illinois | 60611 | — |
| American Health Network | Indianapolis | Indiana | 46254 | — |
| Midwest Institute for Clinical Research | Indianapolis | Indiana | 46260 | — |
| Radiant Research, Inc. | Overland Park | Kansas | 66215 | — |
| L-MARC Research Center | Louisville | Kentucky | 40213 | — |
| Pennington Biomedical Research Center | Baton Rouge | Louisiana | 70808 | — |
| Radiant Research, Inc. | Edina | Minnesota | 55435 | — |
| Diabetes & Endocrinology Specialists | Chesterfield | Missouri | 63017 | — |
| Comprehensive Weight Control Program | New York | New York | 10021 | — |
| Rochester Clinical Research, Inc. | Rochester | New York | 14609 | — |
| Lindner Clinical Trial Center | Cincinnati | Ohio | 45219 | — |
| Covance CRU, Inc. | Portland | Oregon | 97239 | — |
| Diabetes & Glandular Disease Research Associates, Inc. | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00409305, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 20, 2015 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00409305 live on ClinicalTrials.gov.